The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes

Background Previous studies have shown that a variety of biomarkers are closely related to the occurrence and development of early-stage diabetic nephropathy (DN) in patients. The aim of this study was to evaluate the role of multiple sera and urinary biomarkers in the diagnosis of early-stage DN in...

Full description

Bibliographic Details
Main Authors: Deyuan Zhang, Shandong Ye, Tianrong Pan
Format: Article
Language:English
Published: PeerJ Inc. 2019-06-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/7079.pdf
id doaj-0b965c1bf8fe49f8be119f273c56acc7
record_format Article
spelling doaj-0b965c1bf8fe49f8be119f273c56acc72020-11-25T02:06:58ZengPeerJ Inc.PeerJ2167-83592019-06-017e707910.7717/peerj.7079The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetesDeyuan Zhang0Shandong Ye1Tianrong Pan2School of Medicine, Shandong University, Jinan, Shandong, ChinaSchool of Medicine, Shandong University, Jinan, Shandong, ChinaDepartment of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, ChinaBackground Previous studies have shown that a variety of biomarkers are closely related to the occurrence and development of early-stage diabetic nephropathy (DN) in patients. The aim of this study was to evaluate the role of multiple sera and urinary biomarkers in the diagnosis of early-stage DN in patients with type 2 diabetes. Methods We enrolled 287 patients with type 2 diabetes, who were classified into normoalbuminuria (n = 144), microalbuminuria (n = 94), or macroalbuminuria (n = 49) groups based on their urine albumin to creatinine ratios (UACR), along with 42 healthy controls. We assessed 13 biomarkers, including transferrin (Tf), immunoglobulin G (IgG), podocalyxin, neutrophil gelatinase-associated lipocalin (NGAL), N-acetyl-beta-glucosaminidase, α-1-microglobulin, 8-hydroxy-deoxyguanosine, tumor necrosis factor-alpha (TNF-α), and interleukin-18 in urine samples, along with cystatin C, total bilirubin, and uric acid in sera samples, to evaluate their diagnostic roles. From the measurements, the blood neutrophil to lymphocyte ratio was also calculated. Results Urinary Tf, IgG, NGAL, and TNF-α were significantly related to the UACR. We calculated the area under the receiver operating characteristic curves (area under the curve) and found that urinary IgG (0.894), NGAL (0.875), Tf (0.861), TNF-α (0.763), and the combination of urinary Tf + IgG + TNF-α + NGAL (0.922) showed good diagnostic value for early-stage DN. Conclusions Urinary Tf, IgG, NGAL, TNF-α, and the combination of all four biomarkers demonstrated excellent diagnostic value for early-stage DN in patients with type 2 diabetes.https://peerj.com/articles/7079.pdfDiabetic nephropathyProteinuriaInflammationOxidative stressBiomarkers
collection DOAJ
language English
format Article
sources DOAJ
author Deyuan Zhang
Shandong Ye
Tianrong Pan
spellingShingle Deyuan Zhang
Shandong Ye
Tianrong Pan
The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
PeerJ
Diabetic nephropathy
Proteinuria
Inflammation
Oxidative stress
Biomarkers
author_facet Deyuan Zhang
Shandong Ye
Tianrong Pan
author_sort Deyuan Zhang
title The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
title_short The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
title_full The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
title_fullStr The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
title_full_unstemmed The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
title_sort role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
publisher PeerJ Inc.
series PeerJ
issn 2167-8359
publishDate 2019-06-01
description Background Previous studies have shown that a variety of biomarkers are closely related to the occurrence and development of early-stage diabetic nephropathy (DN) in patients. The aim of this study was to evaluate the role of multiple sera and urinary biomarkers in the diagnosis of early-stage DN in patients with type 2 diabetes. Methods We enrolled 287 patients with type 2 diabetes, who were classified into normoalbuminuria (n = 144), microalbuminuria (n = 94), or macroalbuminuria (n = 49) groups based on their urine albumin to creatinine ratios (UACR), along with 42 healthy controls. We assessed 13 biomarkers, including transferrin (Tf), immunoglobulin G (IgG), podocalyxin, neutrophil gelatinase-associated lipocalin (NGAL), N-acetyl-beta-glucosaminidase, α-1-microglobulin, 8-hydroxy-deoxyguanosine, tumor necrosis factor-alpha (TNF-α), and interleukin-18 in urine samples, along with cystatin C, total bilirubin, and uric acid in sera samples, to evaluate their diagnostic roles. From the measurements, the blood neutrophil to lymphocyte ratio was also calculated. Results Urinary Tf, IgG, NGAL, and TNF-α were significantly related to the UACR. We calculated the area under the receiver operating characteristic curves (area under the curve) and found that urinary IgG (0.894), NGAL (0.875), Tf (0.861), TNF-α (0.763), and the combination of urinary Tf + IgG + TNF-α + NGAL (0.922) showed good diagnostic value for early-stage DN. Conclusions Urinary Tf, IgG, NGAL, TNF-α, and the combination of all four biomarkers demonstrated excellent diagnostic value for early-stage DN in patients with type 2 diabetes.
topic Diabetic nephropathy
Proteinuria
Inflammation
Oxidative stress
Biomarkers
url https://peerj.com/articles/7079.pdf
work_keys_str_mv AT deyuanzhang theroleofserumandurinarybiomarkersinthediagnosisofearlydiabeticnephropathyinpatientswithtype2diabetes
AT shandongye theroleofserumandurinarybiomarkersinthediagnosisofearlydiabeticnephropathyinpatientswithtype2diabetes
AT tianrongpan theroleofserumandurinarybiomarkersinthediagnosisofearlydiabeticnephropathyinpatientswithtype2diabetes
AT deyuanzhang roleofserumandurinarybiomarkersinthediagnosisofearlydiabeticnephropathyinpatientswithtype2diabetes
AT shandongye roleofserumandurinarybiomarkersinthediagnosisofearlydiabeticnephropathyinpatientswithtype2diabetes
AT tianrongpan roleofserumandurinarybiomarkersinthediagnosisofearlydiabeticnephropathyinpatientswithtype2diabetes
_version_ 1724931763943243776